Rx drug information, pharmaceutical research, clinical trials, news, and more
FDA Clears Second Remicade Biosimilar (Renflexis) Source: Medscape Dermatology Headlines [2017.04.21]The FDA approves infliximab-abda (Renflexis, Samsung Bioepis) for multiple indications. FDA Approvals
Remicade Phase 3 data show long-term psoriasis response Source: The Doctors Lounge - DermatologyFindings from two Phase 3 studies show high-level, sustained response with maintenance therapy.
All Rights reserved - Copyright DrugLib.com, 2006-2017